We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 105

Germany

  • BARDEHLE PAGENBERG
  • -
  • Germany
  • -
  • September 17 2013

On the regulatory side, the Federal Institute for Drugs and Medical Devices is the authority competent to grant a national marketing authorisation for

Pharmaceutical trademarks 20102011

  • Graf von Westphalen
  • -
  • Germany
  • -
  • September 22 2010

Pharmaceutical trademarks must be selected carefully, as patient safety is at stake

Minus 3 months and 2 weeks

  • Norrbom Vinding
  • -
  • European Union, Germany
  • -
  • September 15 2011

The EU Advocate General says that supplementary protection certificates can be issued with a negative term

Updates on international pricing issues for pharmaceutical and biologic products

  • Sidley Austin LLP
  • -
  • China, European Union, France, Germany, United Kingdom, USA
  • -
  • May 18 2012

Sidley Austin LLP’s Global Life Sciences Team is pleased to provide you with this Global Pricing Newsletter, the first in a periodic series updating clients and friends of the firm on pricing issues around the world that may have an impact on pharmaceutical and biologic manufacturers’ legal and business strategies

Amendments to German Drug Advertising Act

  • Baker & McKenzie
  • -
  • Germany
  • -
  • March 26 2013

Amendments have been made to the German Drug Advertising Act (HeilmittelwerbegesetzHWG) (Act) by the so-called "Second Act Amending Drug Law and

Award procedures in the field of emergency services

  • Schoenherr
  • -
  • Austria, European Union, Germany
  • -
  • February 7 2011

According to the European Court of Justice (ECJ), emergency and rescue transport services are not connected with the exercise of official authority and therefore not exempt from applicability of the Public Procurement Directive (200418EC

Compensating employee inventors

  • Taylor Wessing
  • -
  • Austria, Germany, United Kingdom
  • -
  • January 30 2014

In the life sciences, highly qualified and skilled people are employed in the research and development of new drug candidates and other advancements

Stem cell news - EPO revokes ‘Brüstle’ patent and new CJEU referral on the patentability of parthenotes

  • D Young & Co
  • -
  • European Union, Germany, United Kingdom
  • -
  • June 4 2013

As previously reported in this newsletter (1), the question of the patentability of technology based on the use of human embryonic stem cells (hESC

Germany - unhealthy showdown

  • Freshfields Bruckhaus Deringer LLP
  • -
  • Germany
  • -
  • July 5 2013

The German government has signalled its intention to fight corruption in the healthcare sector before its current term of office comes to an end

Stricter legislation on corruption in healthcare looming

  • Squire Patton Boggs
  • -
  • Germany
  • -
  • March 22 2013

For years there has been a public debate in Germany about corruption in the healthcare sector - not least because of the huge economical detriments